27 June 2017

XING group "Unternehmensbewertung & Spruchverfahren"

LinkedIn group "Shareholders in Germany"

Nidda Healthcare Holding AG: Minimum acceptance threshold for STADA Takeover Offer narrowly missed

- Shareholders representing 65.52 percent of all STADA shares accepted Takeover Offer

- Management and Supervisory Boards recommended and strongly supported Takeover Offer

- Tendered STADA shares to be returned to shareholders

Frankfurt / Munich, 26 June 2017 - The voluntary public Takeover Offer of Nidda Healthcare Holding AG, a holding company controlled by funds advised by Bain Capital Private Equity, LP ("Bain Capital") and by Cinven Partners LLP ("Cinven"), for all outstanding shares of STADA Arzneimittel AG ("STADA" or the "Company") has lapsed due to the non-fulfilment of the minimum acceptance threshold offer condition.

During the acceptance period, which expired on 22 June 2017, the Takeover Offer was accepted for 40,844,263 STADA shares. This represents approximately 65.52 percent of the shares and the voting rights of STADA. The minimum acceptance threshold of 67.5 percent of all STADA shares was therefore narrowly missed despite a highly attractive offer price of EUR 66 per share, the recommendations by the STADA Management and Supervisory Boards and a concerted shareholder outreach by Bain Capital and Cinven as well as the Company. Following the lapse of the offer, shares which were tendered by accepting the Takeover Offer will be returned to the shareholders.

Bain Capital and Cinven worked very closely and constructively with the Management and Supervisory Boards of STADA who recommended and supported the Takeover Offer.

24 June 2017

RHI AG: Cash compensation offer (ad hoc)

06/23/17

As part of the combination of RHI AG with Magnesita S.A., which was announced in a press release on October 5, 2016, it is required to make a cash compensation offer to exiting shareholders for the cross-border merger of RHI AG into RHI – MAG N.V. planned within this transaction.

The Management Board today set the price of the cash compensation of EUR 26.50 per share. This assessment is based on a pure stand-alone view of RHI not including the synergies after closing of the planned transaction.

Further details regarding the merger will be announced in the course of the disclosure of the transaction documentation by June 30, 2017.